Skip to main content
. 2001 Feb;123(2):288–293. doi: 10.1046/j.1365-2249.2001.01457.x

Fig. 1.

Fig. 1

MS patients display increased percentage of reactivity against MBP-peptide (143–168) when compared with MBP-peptide (84–98) and healthy controls. Each dot represents the percentage of positive antigen-reactive TCL measured each patient (see Table 2). *P < 0·05.